πŸ‡ΊπŸ‡Έ FDA
Patent

US 10961261

Oxaborole analogs and uses thereof

granted A61PA61P33/02

Quick answer

US patent 10961261 (Oxaborole analogs and uses thereof) held by The Government of the United States, as represented by the Secretaryof the Army expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States, as represented by the Secretaryof the Army
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P33/02